Detalles de la búsqueda
1.
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.
Br J Cancer
; 130(8): 1249-1260, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361045
2.
Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment.
EMBO J
; 39(6): e104013, 2020 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32009247
3.
Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysis.
Int J Gynecol Cancer
; 31(5): 713-720, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33563640
4.
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Lancet Oncol
; 19(1): 40-50, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29233559
5.
Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer.
Br J Cancer
; 119(9): 1060-1066, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30318511
6.
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
Br J Cancer
; 119(3): 330-338, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29955134
7.
Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 years.
Mod Pathol
; 31(4): 607-615, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29271415
8.
Morphology and tumour-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survival.
Histopathology
; 73(6): 1002-1012, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30007074
9.
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.
Gynecol Oncol
; 150(1): 151-157, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753392
10.
Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and PAI-1 RNA-Binding Protein 1 in Primary and Recurrent Ovarian Cancer: A Study of the Tumor Bank Ovarian Cancer Network.
Gynecol Obstet Invest
; 83(5): 508-514, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-28738361
11.
Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology.
Genes Chromosomes Cancer
; 56(10): 758-766, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28639280
12.
Correction to "Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast CancerâLink to Patient Survival, Hormone Receptor Status, and Metabolic Profiling".
J Proteome Res
; 21(7): 1787, 2022 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35642679
13.
Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study.
Br J Cancer
; 116(10): 1287-1293, 2017 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28350786
14.
Genetic Versus Epigenetic BRCA1 Silencing Pathways: Clinical Effects in Primary Ovarian Cancer Patients: A Study of the Tumor Bank Ovarian Cancer Consortium.
Int J Gynecol Cancer
; 27(8): 1658-1665, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28691938
15.
Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.
Genes Chromosomes Cancer
; 55(8): 626-39, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27106868
16.
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial.
Lancet Oncol
; 17(3): 345-356, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26869049
17.
Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
Ann Surg Oncol
; 23(4): 1279-86, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26832880
18.
Wilms tumor protein 1 (WT1)-- not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma.
Gynecol Oncol
; 140(3): 494-502, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26721227
19.
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes.
BMC Cancer
; 14: 546, 2014 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25070172
20.
Interferon-stimulated gene, 15 kDa (ISG15) in ovarian high-grade serous carcinoma: prognostic impact and link to NF-κB pathway.
Int J Gynecol Pathol
; 33(1): 16-22, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24300530